B Cell Precursor All clinical trials

Explore recruiting b cell precursor all clinical trials.

Recruiting b cell precursor all studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

B Cell Precursor All trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE I/II STUDY TO INVESTIGATE THE SAFETY AND FEASIBILITY OF POINT-OF-CARE HUMAN-CD19 TARGETING CAR T-CELLS IN PAEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL MALIGNANCIES (PACMAN)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Measurable residual disease driven strategy for one or two infusions of nonviral, transposon-manipulated CARCIK CD19 cells. A Phase II study in pediatric and adult patients with relapsed/refractory B cell precursor ALL (BCP-ALL).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescents and young adults: feasibility and safety study (REALL_CART).

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescents and young adults: feasibility and safety study (REALL_CART).

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

B Cell Precursor All trials by city

B Cell Precursor All in Toronto B Cell Precursor All in Vancouver B Cell Precursor All in Montreal B Cell Precursor All in Calgary B Cell Precursor All in Edmonton B Cell Precursor All in Ottawa B Cell Precursor All in Winnipeg B Cell Precursor All in Quebec City B Cell Precursor All in Hamilton B Cell Precursor All in Kitchener B Cell Precursor All in London B Cell Precursor All in Halifax B Cell Precursor All in New York B Cell Precursor All in Los Angeles B Cell Precursor All in Chicago B Cell Precursor All in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease